Daniell Richard

Daniell Richard, EVP Europe Commercial at TEVA, sells 30,000 shares (35% of holdings) as stock nears 52-week highs.

Daniell Richard, EVP Europe Commercial, sold a substantial block representing more than one-third of his holdings at a time when TEVA's stock is trading near its 52-week highs. His prior selling activity over the past two months shows consistent patterns — in the 30-day windows following his earlier March sales, the stock declined, indicating well-timed exits that avoided further downside. However, over longer 90-day periods, those earlier sales preceded modest gains, suggesting his timing works on near-term windows but not intermediate horizons. The company itself remains solidly profitable with healthy revenue and earnings, so this sale does not signal financial distress; rather, it reflects a seasoned executive taking liquidity at a strong price point. This sale marks the continuation of a disciplined selling pattern rather than a sudden shift in conviction.

EVP Richard sells 91,345 TEVA shares for $2,983,516.68 at $32.66 avg; holds 85.8K post-sale

Daniell Richard (EVP, Europe Commercial) executed three separate sales totaling 91,345 shares for $2,983,516.68 on 2026-03-04, reducing his holdings by -51.6% from 177.1K to 85.8K shares. The blended average transaction price of $32.66 sits above the current price of $31.05 and near the 52-week high of $36.25 (within -14.3% of peak). Richard's same-ticker history at TEVA shows two recent prior sales on 2026-03-03 (outcomes not yet measurable) and mixed timing on earlier TEVA trades: his 2025-03-05 paired sales both showed -13.3% 30-day returns but +8.0% 90-day returns, indicating the stock recovered after his sales. His cross-ticker track record of 14 prior sells reflects a 9.09% well-timed rate with +11.1% average 90-day returns, suggesting his prior sales have not consistently preceded declines. The fundamental backdrop shows TEVA with a low P/E of 9.50, positive annual revenue growth of +4.3%, and $433.0M net income, creating a valuation context that does not obviously signal distress.

TEVA EVP Daniell Richard sells 128,985 shares at $32.36 for $4,173,941.71; reduces stake by 51.2%.

Daniell Richard, EVP Europe Commercial at TEVA, executed two separate sales on 2026-03-03, offloading 128,985 shares (129.0K shares) at a blended average of $32.36 for total proceeds of $4,173,941.71 ($4.2M), reducing his post-transaction holdings from 252,112 shares to 123,127 shares—a 51.2% reduction in stake. The transaction occurred at $32.36, which was near the 52-week high of $36.25; the current price is $31.75, down 12.4% from the 52-week high. Across his cross-ticker track record of 15 prior open-market sells, the insider's average 90-day return was +11.1%, with a 90-day well-timed rate of 9.09%; his prior same-ticker sales at TEVA show mixed results, with one 2025 sale producing a -13.3% 30-day return, though his most recent 2025-12-09 sale posted +13.4% at the 30-day mark. The stock's P/E of 9.71, quarterly revenue of $4,480,000,000, and net income of $433,000,000 suggest a lower-valuation industrial/pharma profile; the substantial 51% stake reduction warrants investor attention to understand whether this represents a structural shift in the executive's equity commitment.

Exec. VP Richard Daniell sells 115,468 shares of TEVA at $28.68; exits 70.5% of position

Richard Daniell sold 115,468 shares at $28.68 on 2025-12-09, reducing his TEVA holdings from 163,852 to 48,384 shares, a -70.5% reduction in position size. This is a substantial divestiture of an executive's stake in the pharmaceutical company. At the same ticker, his prior 5 sells (March 2025) showed negative 30-day returns averaging -13.3% but positive 90-day returns averaging +8.0%, indicating those prior exits preceded rallies rather than declines. The current stock price of $30.18 sits at the 52-week high, and the stock has appreciated +20.1% in 30 days and +51.4% in 90 days, suggesting the December transaction occurred well after the recent price momentum had already built. TEVA's valuation is elevated at a P/E of 48.68 despite the company posting negative full-year net income in its most recent fiscal period, which may merit consideration in the context of this large insider departure from holdings.

Exec. VP sells 70,961 shares ($1.1M) at $15.91–$15.90; reduces holding by 59.5% amid stock down 32.5% from high

Daniell Richard, Exec. VP European Commercial at Teva, executed 2 separate sales totaling 70,961 shares for $1,128,642.10 on 2025-03-05 at an average price of $15.91. This transaction reduced his holdings from 119,345 shares to 48,384 shares, a 59.5% reduction. The sale occurred as Teva's stock is trading at $15.36, down 32.5% from its 52-week high of $22.77 and down 10.8% over the past 30 days. Teva's fundamentals remain challenged: the company reported net income of $-437,000,000 for the latest quarter and negative full-year earnings, with revenue growth at only 4.4%. While Richard's cross-ticker track record shows a 33.33% well-timed sell rate over 9 prior sales, his prior trades at Teva provide limited signal (5 recent trades with outcomes not yet measurable). The significant reduction in holdings during a period of material stock weakness merits monitoring of his future trading pattern and any material changes in company performance.

Exec VP Daniell Richard sold 140,372 shares at $15.73–$15.91 for $2,217,406.52 on Mar 4–5, reducing stake 59.2%

Daniell Richard, Exec. VP of European Commercial at TEVA, executed 6 separate sales totaling 140,372 shares for $2,217,406.52 at a blended average price of $15.80 across March 4–5, 2025. This represents a -59.2% reduction in his position (from 237,141 to 96,769 shares). The current stock price of $15.35 sits -32.6% below the 52-week high of $22.77 and has declined -10.0% over the past 30 days and -11.4% over 90 days. At TEVA specifically, Richard's prior three measurable sales showed mixed outcomes (90-day returns: +26.9%, -1.1%, and +3.8%), with only 1 of 3 being well-timed at the 90-day horizon, suggesting inconsistent sell timing at this ticker. The company is currently unprofitable with net income of -$437,000,000 on latest-quarter revenue of $4,332,000,000, adding fundamental uncertainty to the context.

Exec. VP Daniell Richard sells entire 98.9K TEVA stake ($1.7M) at $17.30; exits position completely amid unprofitable operations.

Daniell Richard, Executive VP of European Commercial, liquidated his complete holding of 98.9K shares at $17.30 on 2024-08-12 for $1,711,446.75, leaving zero shares post-transaction. This represents a full exit from his TEVA position. The sale occurs in a company context marked by operational headwinds: TEVA reported a net income of $-846.0M in its latest quarter, with the company unprofitable over its most recent full fiscal year, despite showing annual revenue growth of +6.2%. Notably, Richard's prior two sales at TEVA on 2024-03-04 were both poorly timed by subsequent price action (90-day returns of +26.9%), meaning the stock rallied substantially after those exits. The current sale at $17.30 compares to the current price of $17.13 (within 1% downside), placing the transaction near recent highs (2.3% below the 52-week high of $17.54). The complete liquidation and the company's negative profitability backdrop warrant attention to whether operational deterioration is prompting senior management realignment of holdings.